Forian (FORA) Stock Overview
Provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
FORA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Forian Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.17 |
| 52 Week High | US$2.71 |
| 52 Week Low | US$1.64 |
| Beta | 0.93 |
| 1 Month Change | 0.46% |
| 3 Month Change | 3.33% |
| 1 Year Change | 0.93% |
| 3 Year Change | -9.01% |
| 5 Year Change | -78.06% |
| Change since IPO | -90.52% |
Recent News & Updates
Narrative Update • Mar 25
FORA: Maryland Governance Shift And Assumption Tweaks Will Shape Balanced Outlook
Forian's updated analyst price target in $ has shifted slightly, with analysts citing modest adjustments to the discount rate, profit margin assumptions and the expected future P/E as the main factors driving the revision. What's in the News On January 8, 2026, Forian stockholders approved a change so the company is no longer governed by its existing certificate of incorporation and bylaws and is now governed by a Maryland Charter and Maryland Bylaws (Key Developments).Narrative Update • Mar 11
FORA: Maryland Move And Updated Assumptions Will Shape Balanced Forward Outlook
Analysts have adjusted their price target for Forian to $2.10 per share. This reflects updated assumptions for the discount rate, profit margin and future P/E, while keeping fair value per share broadly aligned with prior estimates.Narrative Update • Feb 25
FORA: Maryland Redomicile And Stable Assumptions Will Support Balanced Forward Outlook
Analysts have made a modest adjustment to their fair value view on Forian, with a slightly lower discount rate and virtually unchanged revenue growth, profit margin, and future P/E assumptions guiding the latest price target update in dollar terms. What's in the News Stockholders approved a change in governing documents on January 8, 2026, moving Forian from its existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.Narrative Update • Feb 09
FORA: Maryland Redomicile And Data Investment Will Support Steady Forward Outlook
Analysts have trimmed their price target on Forian to US$2.10 from US$2.20, citing slightly lower assumed discount rates and modest adjustments to long term revenue growth, profit margin and future P/E expectations. What's in the News Stockholders approved a change in Forian's governing documents on January 8, 2026, moving from the existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.Recent updates
Narrative Update • Mar 25
FORA: Maryland Governance Shift And Assumption Tweaks Will Shape Balanced Outlook
Forian's updated analyst price target in $ has shifted slightly, with analysts citing modest adjustments to the discount rate, profit margin assumptions and the expected future P/E as the main factors driving the revision. What's in the News On January 8, 2026, Forian stockholders approved a change so the company is no longer governed by its existing certificate of incorporation and bylaws and is now governed by a Maryland Charter and Maryland Bylaws (Key Developments).Narrative Update • Mar 11
FORA: Maryland Move And Updated Assumptions Will Shape Balanced Forward Outlook
Analysts have adjusted their price target for Forian to $2.10 per share. This reflects updated assumptions for the discount rate, profit margin and future P/E, while keeping fair value per share broadly aligned with prior estimates.Narrative Update • Feb 25
FORA: Maryland Redomicile And Stable Assumptions Will Support Balanced Forward Outlook
Analysts have made a modest adjustment to their fair value view on Forian, with a slightly lower discount rate and virtually unchanged revenue growth, profit margin, and future P/E assumptions guiding the latest price target update in dollar terms. What's in the News Stockholders approved a change in governing documents on January 8, 2026, moving Forian from its existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.Narrative Update • Feb 09
FORA: Maryland Redomicile And Data Investment Will Support Steady Forward Outlook
Analysts have trimmed their price target on Forian to US$2.10 from US$2.20, citing slightly lower assumed discount rates and modest adjustments to long term revenue growth, profit margin and future P/E expectations. What's in the News Stockholders approved a change in Forian's governing documents on January 8, 2026, moving from the existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.Narrative Update • Jan 26
FORA: Maryland Move And Data Investments Will Support Balanced Forward Outlook
Analysts have slightly reduced their price target on Forian to account for minor changes in key model inputs such as the discount rate and forward P/E, while maintaining their estimate of fair value at US$2.10 per share. What's in the News Stockholders approved Forian's move to be governed by a Maryland Charter and Maryland Bylaws, replacing its prior certificate of incorporation and bylaws, following a special meeting held on January 8, 2026 (company announcement).Narrative Update • Jan 11
FORA: Data Investments And Redomiciling Vote Will Shape Balanced Future Outlook
Analysts have modestly adjusted their price target for Forian, reflecting slightly higher assumed discount rates, a small change in long term profit margin expectations, and a marginally richer future P/E multiple in their updated models. What's in the News Forian has called a special or extraordinary shareholders meeting for January 8, 2026, at 12:00 US Eastern Standard Time to consider a proposal to redomicile from Delaware to Maryland through a statutory conversion (Key Developments).Narrative Update • Dec 21
FORA: Guidance And Data Investments Will Shape Outlook Ahead Of Shareholder Meeting
Analysts have modestly raised their price target on Forian to reflect a slightly higher future earnings multiple of about 29.7 times. At the same time, largely unchanged fair value and growth assumptions indicate a more measured optimism about the company’s long term profit trajectory.Narrative Update • Dec 07
FORA: Guidance, Data Investments And Shareholder Meeting Will Shape Balanced Outlook
Analysts have raised their price target on Forian modestly, citing a slightly higher discount rate and marginally improved expectations for long term profitability and valuation multiples. Together, these factors support a fair value of approximately 2.10 dollars per share.Narrative Update • Nov 23
FORA: Share Buyout Bid And Evolving Guidance Will Shape Outlook
Analysts have significantly reduced their price target for Forian from $5.00 to $2.10 per share, citing lower expected revenue growth and profit margins as the primary factors for the revision. What's in the News A consortium led by Max Wygod has announced plans to acquire the remaining 37% stake in Forian Inc.Analysis Article • Aug 24
Health Check: How Prudently Does Forian (NASDAQ:FORA) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Jul 02
Investors Aren't Entirely Convinced By Forian Inc.'s (NASDAQ:FORA) Revenues
There wouldn't be many who think Forian Inc.'s ( NASDAQ:FORA ) price-to-sales (or "P/S") ratio of 2.8x is worth a...Analysis Article • Feb 12
There's Reason For Concern Over Forian Inc.'s (NASDAQ:FORA) Massive 30% Price Jump
The Forian Inc. ( NASDAQ:FORA ) share price has done very well over the last month, posting an excellent gain of 30...
New Narrative • Jan 26
Integration Of Kyber Data Science Will Provide Differentiated Value To Customers
The acquisition of Kyber Data Science and strategic partnerships are expected to enhance market reach and shareholder value, driving revenue growth.Analysis Article • Aug 18
The Consensus EPS Estimates For Forian Inc. (NASDAQ:FORA) Just Fell A Lot
Market forces rained on the parade of Forian Inc. ( NASDAQ:FORA ) shareholders today, when the covering analyst...Analysis Article • Apr 05
Forian (NASDAQ:FORA) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Investors were disappointed with Forian Inc.'s ( NASDAQ:FORA ) earnings, despite the strong profit numbers. Our...Analysis Article • Apr 03
Unpleasant Surprises Could Be In Store For Forian Inc.'s (NASDAQ:FORA) Shares
Forian Inc.'s ( NASDAQ:FORA ) price-to-sales (or "P/S") ratio of 4.4x may look like a poor investment opportunity when...Analysis Article • Feb 27
Is Forian (NASDAQ:FORA) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • May 05
Investors Give Forian Inc. (NASDAQ:FORA) Shares A 28% Hiding
The Forian Inc. ( NASDAQ:FORA ) share price has fared very poorly over the last month, falling by a substantial 28...Shareholder Returns
| FORA | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0.9% | -5.9% | -0.3% |
| 1Y | 0.9% | -42.0% | 24.1% |
Return vs Industry: FORA exceeded the US Healthcare Services industry which returned -44.4% over the past year.
Return vs Market: FORA underperformed the US Market which returned 26.7% over the past year.
Price Volatility
| FORA volatility | |
|---|---|
| FORA Average Weekly Movement | 1.5% |
| Healthcare Services Industry Average Movement | 10.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: FORA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: FORA's weekly volatility has decreased from 7% to 1% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 50 | Max Wygod | forian.com |
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company’s subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries.
Forian Inc. Fundamentals Summary
| FORA fundamental statistics | |
|---|---|
| Market cap | US$67.79m |
| Earnings (TTM) | -US$2.87m |
| Revenue (TTM) | US$30.26m |
2.2x
P/S Ratio-23.6x
P/E RatioIs FORA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FORA income statement (TTM) | |
|---|---|
| Revenue | US$30.26m |
| Cost of Revenue | US$14.16m |
| Gross Profit | US$16.10m |
| Other Expenses | US$18.97m |
| Earnings | -US$2.87m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.092 |
| Gross Margin | 53.21% |
| Net Profit Margin | -9.50% |
| Debt/Equity Ratio | 0% |
How did FORA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/16 15:43 |
| End of Day Share Price | 2026/05/14 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Forian Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Baldry | Roth Capital Partners |